Avista Public Acquisition Corp. II Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AHPAU and buy or sell other stocks, ETFs, and their options commission-free!About AHPAU
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies.
CEOMatthew William Foehr
CEOMatthew William Foehr
Employees114
Employees114
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2015
Founded2015
Employees114
Employees114
AHPAU Key Statistics
Market cap752.35M
Market cap752.35M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.23K
Average volume2.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.48
52 Week high$10.48
52 Week low$6.16
52 Week low$6.16
Stock Snapshot
The current Avista Public Acquisition Corp. II Unit(AHPAU) stock price is $6.16, with a market capitalization of 752.35M.
Avista Public Acquisition Corp. II Unit(AHPAU) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
Avista Public Acquisition Corp. II Unit(AHPAU) shares are trading with a volume of 0, against a daily average of 2.23K.
In the last year, Avista Public Acquisition Corp. II Unit(AHPAU) shares hit a 52-week high of $10.48 and a 52-week low of $6.16.
In the last year, Avista Public Acquisition Corp. II Unit(AHPAU) shares hit a 52-week high of $10.48 and a 52-week low of $6.16.